MANDACI ŞANLI, N. Et Al. 2022. Pretransplant Serum Fibrinogen Level may be a Predictive Marker on Chronic Graft-Versus-Host Disease (cGVHD) in Patients Having Undergone Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT). UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , vol.32, no.1 , 8-15.

MANDACI ŞANLI, N., Keklik, M., & Unal, A., (2022). Pretransplant Serum Fibrinogen Level may be a Predictive Marker on Chronic Graft-Versus-Host Disease (cGVHD) in Patients Having Undergone Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT). UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , vol.32, no.1, 8-15.

MANDACI ŞANLI, NESLİHAN, MUZAFFER KEKLİK, And Ali Unal. "Pretransplant Serum Fibrinogen Level may be a Predictive Marker on Chronic Graft-Versus-Host Disease (cGVHD) in Patients Having Undergone Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)," UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , vol.32, no.1, 8-15, 2022

MANDACI ŞANLI, NESLİHAN M. Et Al. "Pretransplant Serum Fibrinogen Level may be a Predictive Marker on Chronic Graft-Versus-Host Disease (cGVHD) in Patients Having Undergone Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)." UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , vol.32, no.1, pp.8-15, 2022

MANDACI ŞANLI, N. Keklik, M. And Unal, A. (2022) . "Pretransplant Serum Fibrinogen Level may be a Predictive Marker on Chronic Graft-Versus-Host Disease (cGVHD) in Patients Having Undergone Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)." UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , vol.32, no.1, pp.8-15.

@article{article, author={NESLİHAN MANDACI ŞANLI Et Al. }, title={Pretransplant Serum Fibrinogen Level may be a Predictive Marker on Chronic Graft-Versus-Host Disease (cGVHD) in Patients Having Undergone Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)}, journal={UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI}, year=2022, pages={8-15} }